We are live on
!
Find out more
CPC
Cookson Peirce & Co Portfolio holdings
AUM
$3.04B
1-Year Est. Return
94.11%
This Fund
S&P 500
This Quarter
Est. Return
+18.73%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.47B
AUM Growth
+$140M
(+11%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
33.28%
Holding
191
New
53
Increased
62
Reduced
37
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$31.9M |
| 2 |
Pinterest
PINS
|
+$27.2M |
| 3 |
NovoCure
NVCR
|
+$22.8M |
| 4 |
Infosys
INFY
|
+$22.1M |
| 5 |
D.R. Horton
DHI
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$43.4M |
| 2 |
Moody's
MCO
|
+$43.1M |
| 3 |
Akamai
AKAM
|
+$42.5M |
| 4 |
Eli Lilly
LLY
|
+$42.1M |
| 5 |
DexCom
DXCM
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Communication Services | 15.59% |
| 3 | Consumer Discretionary | 13.79% |
| 4 | Industrials | 12.31% |
| 5 | Healthcare | 12.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
Moody's
MCO
$82.8B
| – | – |
-148,564
| Closed | -$43.1M |
|
177
Nasdaq
NDAQ
$52.7B
| – | – |
-48,825
| Closed | -$2M |
|
178
Protolabs
PRLB
$1.79B
| – | – |
-8,581
| Closed | -$1.11M |
|
179
Regeneron Pharmaceuticals
REGN
$78.5B
| – | – |
-987
| Closed | -$553K |
|
180
Repligen
RGEN
$7.96B
| – | – |
-7,888
| Closed | -$1.16M |
|
181
ResMed
RMD
$30.6B
| – | – |
-1,497
| Closed | -$257K |
|
182
SAP
SAP
$212B
| – | – |
-1,720
| Closed | -$268K |
|
183
Sanofi
SNY
$103B
| – | – |
-278,576
| Closed | -$14M |
|
184
Sony
SONY
$137B
| – | – |
-59,015
| Closed | -$906K |
|
185
Visa
V
$684B
| – | – |
-2,083
| Closed | -$417K |
|
186
Vicor
VICR
$9.56B
| – | – |
-11,008
| Closed | -$856K |
|
|
187
Vertex Pharmaceuticals
VRTX
$121B
| – | – |
-159,556
| Closed | -$43.4M |
|
188
Werner Enterprises
WERN
$2.24B
| – | – |
-73,908
| Closed | -$3.1M |
|
189
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
| – | – |
-5,832
| Closed | -$374K |
|
|
CTXS
190
DELISTED
Citrix Systems Inc
CTXS
| – | – |
-137,486
| Closed | -$18.9M |
|
|
BSCL
191
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
| – | – |
-503,918
| Closed | -$10.7M |
|
Similar funds
MB
MCM
MCM
LFAS
EP
SAG
CLG
CM
Cookson Peirce & Co's Q4 2020 Portfolio in Review
As of Q4 2020, Cookson Peirce & Co held 191 positions worth $1.47B, up 11% from $1.33B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Cookson Peirce & Co's Q4 2020 filing shows 53 new, 62 increased, 37 reduced and 37 closed positions. Its largest new stake was Freeport-McMoran: 1,533,470 shares worth $39.9M. The largest sale was Vertex Pharmaceuticals, an estimated $43.4M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Cookson Peirce & Co's largest Q4 2020 buy was Freeport-McMoran: 1,533,470 shares worth $39.9M.
- Cookson Peirce & Co added most to NovoCure in Q4 2020, an estimated $22.8M increase.
- Cookson Peirce & Co's biggest Q4 2020 reduction was Insulet, cutting an estimated $1.59M.
- Cookson Peirce & Co fully exited Vertex Pharmaceuticals in Q4 2020, selling an estimated $43.4M.
- Cookson Peirce & Co's ten largest holdings make up 33% of its $1.47B portfolio in Q4 2020.
- Cookson Peirce & Co opened 53 new positions and closed 37 in Q4 2020.
- Cookson Peirce & Co's portfolio value rose 11% quarter-over-quarter to $1.47B.
Based on Cookson Peirce & Co's 13F filing for Q4 2020, filed 10 Feb 2021.